Prevalences of vaccine-induced, infection-induced, and hybrid* immunity† against SARS-CoV-2 among blood donors aged ≥16 years, by age group — United States, April 2021–September 2022
* Immunity derived from a combination of vaccination and infection.
† Ascertained by the presence of anti-spike antibodies (present in both COVID-19–vaccinated and SARS-CoV-2–infected persons) and anti-nucleocapsid antibodies (present only in previously infected persons) and self-reported history of vaccination.